Wenyuan Zhang

Dr. Wenyuan Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Computers in Biology and Medicine
Verified
Journal Article
Open access
WZWenyuan Zhang
Wenyuan Zhang
Sepsis, characterized by systemic inflammatory response syndrome and life-threatening organ dysfunction, remains a significant global cause of disability and death. Despite its impact, reliable biomarkers for sepsis diagnosis are yet to be identified. This study aims to investigate and identify key genes and pathways in sepsis through the analysis of multiple microarray datasets, providing potential treatment targets for future clinical trials. Two independent gene expression profiles (GSE54514 and GSE69528) were downloaded from the Gene Expression Omnibus (GEO) database. After merging and batch normalization, differentially expressed genes (DEGs) were obtained using the "limma" package. Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA) were performed using "R" software. A Protein-Protein Interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes (STRING). The top 10 hub genes were identified using Cytoscape. A Nomogram model for predicting sepsis occurrence was constructed and evaluated. Bioinformatic analysis of 210 sepsis and 91 control blood samples identified 72 DEGs. GO analyses revealed associations with immune response processes. GSEA indicated involvement in key signaling pathways. S100A12, MMP9, and PRTN3 were identified as independent risk factors for sepsis. This study unveils critical genes and pathways in sepsis through bioinformatic methods. S100A12, MMP9, and PRTN3 may play essential roles in the immune response to infection, influencing sepsis prognosis.

9 January 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
CHChunsheng Huang
Chunsheng Huang
QTQiaoling Tong
Qiaoling Tong
WZWenyuan Zhang
Wenyuan Zhang
ZPZhihao Pan
Zhihao Pan
Objective: In addition to its antiplatelet and anti-inflammatory properties, aspirin inhibits bacterial proliferation directly. The potential benefits of aspirin may enhance the prognosis for sepsis patients. However, little is known about the effects of early aspirin administration. This study aimed to examine the correlation between the administration of aspirin at an early stage and the 90-day mortality rate among sepsis patients.Methods: In order to distinguish between septic patients who received early aspirin treatment and those who did not, queries were conducted on the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The principal metric utilized was 90-day mortality. We determined the association between early aspirin use and 90-day mortality using multivariate Cox regression, and propensity score matching (PSM) was utilized to validate our findings. The analyses of the subgroups have been completed.Results: Our analysis comprised 28,425 septic patients, of whom 7,568 (26.6%) received aspirin within 24 h of intensive care unit (ICU) admission. The aspirin users group had a lower 90-day mortality than the aspirin nonusers group [1,624 (21.8%) vs. 2,035 (27.3%), P < 0.001]. The logistic regression showed that early aspirin use was associated with a lower 90-day mortality (OR, 0.74, 95% CI, 0.69–0.80, P < 0.001). K-M curve analysis showed that the 90-day mortality of the aspirin users group was significantly lower than that of the aspirin nonusers group (P < 0.001). Subgroup analysis revealed comparable relationships between early aspirin use and 90-day mortality among individuals.Conclusion: In conclusion, early aspirin use was associated with decreased in-hospital and 90-day mortality in septic patients, emphasizing the significance of early aspirin use administration in the ICU.

1 September 2023 in Stroke
Verified
Journal Article
Closed access
LSLiqi Shu
Liqi Shu
WZWenyuan Zhang
Wenyuan Zhang
SYShadi Yaghi
Shadi Yaghi
AGAnais Grilli
Anais Grilli
AHAdam de Havenon
Adam de Havenon
EGEric Goldstein
Eric Goldstein

30 July 2026 in Jornal de Pediatria
Verified
Journal Article
Open access
JZJialian Zhao
Jialian Zhao
CJChunyi Jin
Chunyi Jin
GAGuihang An
Guihang An
MGMei Guo
Mei Guo
WZWenyuan Zhang
Wenyuan Zhang
JJJin Jin
Jin Jin
Intraoperative hypotension is associated with adverse postoperative outcomes, yet evidence in the neonatal population is limited. This study aimed to investigate the incidence, risk factors, and prognostic significance of intraoperative hypotension in this population. This single-center retrospective study included 1712 neonates undergoing non-cardiac surgery from 2020 to 2025 at a tertiary children's hospital in China. Intraoperative hypotension was defined as a reduction in mean arterial pressure of more than 20% from the preoperative baseline and lasting for more than 5 min. Multivariate logistic regression identified independent risk factors. The incidence of intraoperative hypotension was 59.8% (1024/1712). Independent risk factors included American Society of Anesthesiologists Physical Status Classification > Ⅲ (OR = 1.357, 95% CI: 1.079-1.706, P = 0.009), emergency surgery (OR = 1.323, 95% CI: 1.054-1.660, P = 0.016), surgery duration > 60 min (OR = 1.457, 95% CI: 1.162-1.826, P = 0.001), thoracic surgery (OR = 1.727, 95% CI: 1.053-2.831, P = 0.030), preoperative congenital heart disease (OR = 1.379, 95% CI: 1.117-1.702, P = 0.003), and preoperative acidosis (OR = 1.349, 95% CI: 1.036-1.757, P = 0.026). Higher gestational age (OR = 0.936, 95% CI: 0.891-0.983, P = 0.008) and neurosurgery (OR = 0.566, 95% CI: 0.385-0.832, P = 0.004) were protective factors. Intraoperative hypotension was associated with prolonged postoperative recovery and increased acute kidney injury and intraventricular hemorrhage (all P < 0.05). Intraoperative hypotension is highly prevalent in neonatal non-cardiac surgery and was associated with short-term outcomes. Identified risk and protective factors may guide perioperative hemodynamic optimization in this vulnerable population.